# Dianthus Therapeutics, Inc.: Form SC 13D, filed Sep 21, 2023

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: SC 13D
- Filed: 2023-09-21
- Accepted by EDGAR: Sep 21, 2023, 16:32 ET
- Period: not reported
- Accession: 0001193125-23-239624
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312523239624/d495884dsc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312523239624/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312523239624/d495884dsc13d.htm

Filed Sep 21, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-239624. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.
